Back to search
FDAFDA · Food and drugs·Recall number D-1159-2018

Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

Published September 5, 2018 · Recall initiated: August 21, 2018

Summary

FDA records drug Class II recall D-1159-2018, published September 5, 2018 and initiated August 21, 2018. Recalling firm: Auro Pharmacies, Inc.; Status: Terminated; Reported quantity: 183 vials; Lot: Lot #: 180716/21, Exp 14-Oct-18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Auro Pharmacies, Inc.
Distributor
Nationwide in USA
Lot
Lot #: 180716/21, Exp 14-Oct-18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631 recalled?

Yes. FDA published recall D-1159-2018 on September 5, 2018. Reported hazard: Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

What should I do if I have this product?

Voluntary: Firm initiated · Letter